RAJENDRA BELLAM: Open Payments
NPI 1053392969 · DUNNELLON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,707 in 181 payments from 20 companies in 2025. Trend: 2023 $3,856 · 2024 $5,489 · 2025 $8,707
Consulting: $4,125Food & beverage: $4,010Travel & lodging: $412Education: $85Speaker / faculty: $75
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $4,798 |
| AstraZeneca Pharmaceuticals LP | 38 | $1,249 |
| Novo Nordisk Inc | 23 | $436 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $327 |
| ABBVIE INC. | 17 | $321 |
| GlaxoSmithKline, LLC. | 20 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $267 |
| Astellas Pharma US Inc | 7 | $207 |
| Lilly USA, LLC | 9 | $157 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
Products named: VYNDAQEL, BREZTRI, AIRSUPRA, VYNDAMAX, CAPLYTA, TRELEGY ELLIPTA, Ozempic, JARDIANCE.
Industry payments across FL — which companies pay providers there.
